Concepedia

Takafumi Yukawa

TY

Statistics

Publications

10

Citations

296

H-Index

10

Active since

2008

Affiliations

Tri-Institutional Therapeutics Discovery Institute(Current)

Weill Cornell Medicine

Schrodinger (United States)

Cornell University

The University of Tokyo

Takafumi Yukawa is an author at Tri-Institutional Therapeutics Discovery Institute specializing in drug development, medicinal chemistry, and drug discovery.

ORCID

Top concepts

Publications per year

2008–2023

10

Publications

10

Catalytic Asymmetric Aza-Morita−Baylis−Hillman Reaction of Methyl Acrylate: Role of a Bifunctional La(O-<i>i</i>Pr)<sub>3</sub>/Linked-BINOL Complex

Takafumi Yukawa, Bianca Seelig, Yingjie Xu et al. · Journal of the American Chemical Society · 2010 · 77 citations

Lewis Base Assisted Brønsted Base Catalysis: Bidentate Phosphine Oxides as Activators and Modulators of Brønsted Basic Lanthanum–Aryloxides

Hiroyuki Morimoto, Tatsuhiko Yoshino, Takafumi Yukawa et al. · Angewandte Chemie International Edition · 2008 · 56 citations

Development of a Highly Selective <i>Plasmodium falciparum</i> Proteasome Inhibitor with Anti‐malaria Activity in Humanized Mice

Wenhu Zhan, Hao Zhang, John D. Ginn et al. · Angewandte Chemie International Edition · 2021 · 38 citations · Full text

Discovery and optimization of 1,7-disubstituted-2,2-dimethyl-2,3-dihydroquinazolin-4(1H)-ones as potent and selective PKCθ inhibitors

Taisuke Katoh, Takafumi Takai, Takafumi Yukawa et al. · Bioorganic & Medicinal Chemistry · 2016 · 26 citations · Full text

, , +10

Direct and Regioselective Monofluorination of <i>N</i>-Protected Pyridone Derivatives using <i>N</i>-Fluorobenzenesulfonimide (NFSI)

Fumie Sakurai, Takafumi Yukawa, Takahiko Taniguchi · Organic Letters · 2019 · 23 citations

1–5 of 10